DUSTIN LOGUE: Open Payments
NPI 1003146226 · BAKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 62 payments from 23 companies in 2025. Trend: 2023 $1,010 · 2024 $968 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $144 |
| Ardelyx, Inc. | 8 | $138 |
| Abbott Laboratories | 3 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Lundbeck LLC | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| PFIZER INC. | 3 | $47 |
Products named: CAPLYTA, IBSRELA, VRAYLAR, FREESTYLE LIBRE 3, Kerendia, REXULTI, FANAPT, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
